METACRINE INC's ticker is MTCR and the CUSIP is 59101E103. A total of 33 filers reported holding METACRINE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $113,987 | -7.3% | 254,492 | 0.0% | 0.00% | – |
| Q3 2022 | $123,000 | -45.3% | 254,492 | -43.2% | 0.00% | – |
| Q2 2022 | $225,000 | -14.8% | 448,426 | +3.5% | 0.00% | – |
| Q1 2022 | $264,000 | -9.3% | 433,304 | +0.2% | 0.00% | – |
| Q4 2021 | $291,000 | -79.4% | 432,382 | +4.8% | 0.00% | – |
| Q3 2021 | $1,415,000 | -8.8% | 412,382 | +1.1% | 0.00% | – |
| Q2 2021 | $1,551,000 | +1.1% | 408,080 | +65.0% | 0.00% | – |
| Q1 2021 | $1,534,000 | +94.4% | 247,271 | +146.3% | 0.00% | – |
| Q4 2020 | $789,000 | -3.4% | 100,399 | +25.5% | 0.00% | – |
| Q3 2020 | $817,000 | – | 80,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 869,082 | $3,303,000 | 2.06% |
| venBio Partners LLC | 3,059,123 | $11,625,000 | 1.37% |
| APOGEM CAPITAL LLC | 67,322 | $256,000 | 0.16% |
| NEA Management Company, LLC | 3,062,977 | $11,639,000 | 0.15% |
| Artal Group S.A. | 924,898 | $3,515,000 | 0.07% |
| ArrowMark Colorado Holdings LLC | 1,046,141 | $3,975,000 | 0.03% |
| Vivo Capital, LLC | 146,426 | $556,000 | 0.02% |
| CIM INVESTMENT MANAGEMENT INC | 19,054 | $72,000 | 0.02% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 277,469 | $1,054,000 | 0.02% |
| Edge Wealth Management LLC | 10,600 | $40,000 | 0.01% |